In neovascular age-related macular degeneration (AMD), OFA peripheral-macular hypersensitivity predicts good responses to initial antivascular endothelial growth factor (VEGF) treatment (13) and even the need for treatment (14). The gene discussed is VEGFA; the disease is age-related macular degeneration.